Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...